Published in
Springer, Targeted Oncology, 3(17), p. 377-377, 2022
DOI: 10.1007/s11523-022-00881-2
Links
Tools
Correction to: A Phase 1 Study of Sapanisertib (TAK-228) in East Asian Patients with Advanced Nonhematological Malignancies
Journal article published in 2022 by
Toshio Shimizu 
,
Yasutoshi Kuboki ,
Chia-Chi Lin ,
Kan Yonemori ,
Tomoko Yanai ,
Douglas V. Faller ,
Lwona Dobler ,
Neeraj Gupta ,
Farhad Sedarati,
Kyu-Pyo Kim
,
Yasutoshi Kuboki ,
Chia-Chi Lin ,
Kan Yonemori ,
Tomoko Yanai ,
Douglas V. Faller ,
Lwona Dobler ,
Neeraj Gupta ,
Farhad Sedarati,
Kyu-Pyo Kim
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 